These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33633044)

  • 21. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 22. A Meta-Analysis Comparing Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Disease.
    Kodumuri V; Balasubramanian S; Vij A; Siddamsetti S; Sethi A; Khalafallah R; Khosla S
    Am J Cardiol; 2018 Apr; 121(8):924-933. PubMed ID: 29502793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-year outcomes following PCI with DES versus CABG for unprotected LM coronary lesions: meta-analysis and meta-regression of 2914 patients.
    Sá MP; Ferraz PE; Escobar RR; Nunes EO; Soares AM; Araújo e Sá FB; Vasconcelos FP; Lima RC
    Rev Bras Cir Cardiovasc; 2013 Mar; 28(1):83-92. PubMed ID: 23739937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of coronary artery bypass grafting and drug-eluting stents in patients with chronic kidney disease and multivessel disease: A meta-analysis.
    Wang Y; Zhu S; Gao P; Zhang Q
    Eur J Intern Med; 2017 Sep; 43():28-35. PubMed ID: 28400078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of percutaneous coronary intervention versus coronary artery bypass grafting in left main coronary artery disease: A systematic review and meta-analysis.
    Garg A; Rout A; Raheja H; Hakeem H; Sharma S
    Catheter Cardiovasc Interv; 2021 Sep; 98(3):427-433. PubMed ID: 33103847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis.
    Li X; Kong M; Jiang D; Dong A
    Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):347-54. PubMed ID: 24345688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis.
    Zhang XL; Zhu QQ; Yang JJ; Chen YH; Li Y; Zhu SH; Xie J; Wang L; Kang LN; Xu B
    BMC Med; 2017 Apr; 15(1):84. PubMed ID: 28427392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous coronary intervention versus coronary artery bypass graft surgery in dialysis-dependent patients: A pooled meta-analysis of reconstructed time-to-event data.
    Tasoudis PT; Varvoglis DN; Tzoumas A; Doulamis IP; Tzani A; Sá MP; Kampaktsis PN; Gallo M
    J Card Surg; 2022 Oct; 37(10):3365-3373. PubMed ID: 35900307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-Eluting Stent Versus Coronary Artery Bypass Grafting for Diabetic Patients With Multivessel and/or Left Main Coronary Artery Disease: A Meta-Analysis.
    Cui K; Lyu S; Song X; Liu H; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Angiology; 2019 Sep; 70(8):765-773. PubMed ID: 30995117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ten-year Outcomes After Drug-Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow-Up Study.
    Jeong YJ; Ahn JM; Hyun J; Lee J; Kim JH; Yang Y; Choe K; Park H; Kang DY; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park SJ; Park DW
    J Am Heart Assoc; 2021 Jul; 10(14):e019834. PubMed ID: 34238026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early and late outcomes of coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stents for dialysis patients.
    Terazawa S; Tajima K; Takami Y; Tanaka K; Okada N; Usui A; Ueda Y
    J Card Surg; 2012 May; 27(3):281-7. PubMed ID: 22500723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease.
    De Luca G; Schaffer A; Verdoia M; Suryapranata H
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):344-54. PubMed ID: 24373711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: comprehensive systematic review and meta-analysis of randomized clinical data.
    Hakeem A; Garg N; Bhatti S; Rajpurohit N; Ahmed Z; Uretsky BF
    J Am Heart Assoc; 2013 Aug; 2(4):e000354. PubMed ID: 23926119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.
    Sunagawa G; Komiya T; Tamura N; Sakaguchi G; Kobayashi T; Murashita T
    Ann Thorac Surg; 2010 Jun; 89(6):1896-900; discussion 1900. PubMed ID: 20494045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?
    Bangalore S; Toklu B; Feit F
    Circ Cardiovasc Interv; 2014 Aug; 7(4):518-25. PubMed ID: 24939927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary surgery is superior to drug eluting stents in multivessel disease. Systematic review and meta-analysis of contemporary randomized controlled trials.
    Benedetto U; Gaudino M; Ng C; Biondi-Zoccai G; D'Ascenzo F; Frati G; Girardi LN; Angelini GD; Taggart DP
    Int J Cardiol; 2016 May; 210():19-24. PubMed ID: 26922707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
    Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
    Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior descending artery.
    Matsoukis IL; Karanasos A; Patsa C; Anousakis-Vlachochristou N; Triantafyllou K; Kantzanou M; Drakopoulou M; Tsiamis E; Latsios G; Synetos A; Petridou ET; Tousoulis D; Toutouzas K
    Catheter Cardiovasc Interv; 2021 Sep; 98(3):447-457. PubMed ID: 32865856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.